drugset / Trial / NCT00549692

Efficacy and Safety of Omega-3 Fatty Acids(Omacor®) for the Treatment of Immunoglobulin A Nephropathy

NCT00549692

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to compare omega-3 fatty acids with placebo for efficacy in retardation of increase of serum creatinine(SCr) in IgA Nephropathy

Timeline

Start
2007-11
Primary completion
2012-08
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 2 g